In 2022, ASPS began tracking male breast augmentation patients for the first time. The numbers are small — but combined with gynecomastia, nearly 28,300 men had breast surgery in 2024. That's 3.7% of total breast surgery volume.
In its 2022 annual statistics, ASPS added a line item that had never appeared before: male patients undergoing breast augmentation. The numbers are modest but consistent — roughly 1,800 per year, holding steady at 0.6% of total augmentation volume. The fact that the category exists at all signals a shift in how the industry views gender and breast surgery.
While male augmentation is new, male breast reduction has been tracked for decades and represents a far larger market. At 26,430 procedures in 2024, gynecomastia is 14 times larger than male augmentation. It's been one of the top 5 male cosmetic surgical procedures for over a decade, holding remarkably stable at 20,000–28,000 per year.
Combining augmentation and reduction, nearly 28,300 men had breast surgery in 2024 — a number that would surprise most people. The vast majority (93%) were having tissue removed, not added. But the combined market is growing at roughly 4% per year and represents 3.7% of total breast surgery volume.
Gynecomastia has been the #1 cosmetic surgical procedure for teenage males for the entire dataset — roughly 75% of all teen male cosmetic surgery. While teen female augmentation collapsed, teen male breast reduction has held stable at 14,000–17,000 per year.
Male breast augmentation is, by the numbers, a footnote — 1,862 procedures against 306,196 total augmentations. But its presence in the data represents something larger than its volume: the formal recognition that breast surgery is no longer exclusively a female domain.
The sharp deceleration from year one to year two suggests either a one-time correction (initial undercounting) or that growth has already plateaued. With only 3 years of data, projecting trends is inherently speculative.